Delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in Cannabis sativa, acting as a partial agonist at CB1 receptors; used medically for chronic pain, chemotherapy-induced nausea, appetite stimulation, and spasticity. Subject to legal restrictions varying by jurisdiction.
Morning sickness, motion sickness, medication-induced nausea, and general stomach upset.
Also known as: THC, Delta-9-tetrahydrocannabinol, Marijuana, Cannabis sativa
Every published result for this pair, extracted and audited.
Research volume over time for Cannabis (THC) × nausea. Structured outcome extraction (direction, effect size) for this pair is in progress - the full analytics will appear here once audited.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Cannabis-Based Products for Chronic Pain : An Updated Systematic ReviewChou R, et al. · Annals of internal medicine · 2026PMID 41429020 ↗02Comparative Effectiveness of Pharmacological and Non-Pharmacological Interventions for Nausea and Vomiting in Pregnancy: A Systematic Review and Network Meta-AnalysisFrivaldszky L, et al. · Nutrients · 2026PMID 42075106 ↗03The effects of oral cannabidiol supplementation on blood pressure in adults: a systematic review of randomised controlled trialsRoberts A, et al. · Journal of cannabis research · 2026PMID 42321899 ↗04Pharmacological properties of ginger (Zingiber officinale): what do meta-analyses say? a systematic reviewPaudel KR, et al. · Frontiers in pharmacology · 2025PMID 40808693 ↗Be the first to share what you noticed with Cannabis (THC) for nausea. How we calculate this.